• With an Impressive $1M in Presale, Qubetics Steals the Show While VeChain and Pyth Network Rise
• Analyst Says Dogecoin’s Top 10 Ranking Doesn’t Make it a Good Buy, Reveals 4 Better Cryptos to Achieve a $15M Portfolio by 2026.
• Crypto Whitehat Hackers Still Prefer Ethereum In 2024
• National Bank of Bahrain Supports Bitcoin With New Investment Product
• MicroStrategy’s Bitcoin Strategy Could Boost Stock by 64%: Analysts
• Robinhood Chief Legal Officer Now Leading Candidate to Lead SEC If Trump Wins
• Bybit Launchpool Introduces SUI Pool and Replaces USDT with USDC
• Vitalik Buterin Charity Donation from MOODENG Token Sale
• VENKO Achieves Key Milestones and Expands Utility with Alien-Themed Ecosystem on Solana
• BlockDAG Presale Momentum Targets $600M in 2 Months! BNB’s Argentina Win & PEPE Price Dynamics Revealed
Vitalik Buterin Charity Donation from MOODENG Token Sale
3 hours ago - Around 1 mins mins to read
Key Points:
- Vitalik Buterin sold 10 billion MOODENG tokens for 308.7 ETH, donating 260.15 ETH to the Kanro charity for anti-airborne-disease technology.
- Vitalik supports memecoin charity donations, encouraging communities to donate directly or form DAOs to engage in positive-sum contributions.
Vitalik Buterin sold 10 billion MOODENG tokens for 308.7 ETH, donating 260.15 ETH to Kanro charity, emphasizing Vitalik Buterin Charity Donation for disease research.
Vitalik Buterin Charity Donation Supports Disease Research
Vitalik Buterin sold 10 billion MOODENG tokens for 308.7 ETH and then sent 260.15 ETH to the Kanro charity. The donation will fund anti-airborne-disease technologies. He praised memecoins giving something to charities and asked more communities to engage in charity-focused initiatives.
Read more: MegaETH Review: Layer 2 Invested by Vitalik Buterin
Vitalik Buterin’s Commitment to Charity Through Memecoins
As part of his trend of donating proceeds from his sale of MOODENG tokens, Vitalik Buterin fosters memecoin community maximal positivity-sum; this time, the proceeds go to the development of solutions for airborne diseases.
DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |